​​​​JEFFREY ADELGLASS, M.D., F.A.C.S.
​mICHELE rEYNOLDS, m.D., CPI
​CLINICAL RESEARCH STUDIES
​Dallas | ft. worth TEXAS

​​​ currently enrolling subjects for
​PAID CLINICAL RESEARCH participation

​Each year, an estimated 58,000-80,000 children under 5 are hospitalized in the U.S. due to infection caused by the highly contagious Respiratory Syncytial Virus.


Research Your Health is Enrolling an

RSV Vaccine Study for Children in 2 Age Groups:

•6 Months and• 12 Months


The CORAL Study is a Phase 3 research study evaluating an experimental RSV Vaccine in healthy infants and toddlers and how children respond to it along with their recommended pediatric routine vaccinations.


Children participating in the study will receive their routine (6-month and 12-month) vaccinations at no charge. Study participation consists of 4 or 5 visits to our study center, and 5 phone calls from our study staff. All children will receive the investigational vaccine and a placebo treatment during the couirse of the study. Participation in the study lasts about 9 months.


For More Info about This or Other Studies:

Call (972) 746-2222

Research Your Health

Jeffrey Adelglass, M.D., F.A.C.S.

6020 W. Parker Rd. | Suite 430 | Plano, Texas 75093

ResearchYourHealth.com




RSV infections can be dangerous for infants and young children. Each year, an estimated 58,000-80,000 children under 5 are hospitalized in the U.S. due to infection caused by the highly contagious Respiratory Syncitial Virus. Research Your Health is Enrolling an RSV Vaccine Study for Children in 2 Age Groups: • 6 Months and • 12 Months The CORAL Study is a Phase 3 research study evaluating an experimental RSV Vaccine in healthy infants and toddlers and how children respond to it along with their recommended pediatric routine vaccinations. Children participating in the study will receive their routine (6-month and 12-month) vaccinations at no charge. Study participation consists of 4 or 5 visits to our study center, and 5 phone calls from our study staff. All children will receive the investigational vaccine and a placebo treatment during the couirse of the study. Participation in the study lasts about 9 months. For More Info about This or Other Studies: Call (972) 746-2222 Jeffrey Adelglass, M.D., F.A.C.S. | Research Your Health | 6020 W. Parker Rd. | Suite 430 | Plano, Texas 75093 ResearchYourHealth.com